Martin G. Zeier

Martin G. Zeier's AcademicInfluence.com Rankings

Martin G. Zeier

Philosophy

#8078

World Rank

#11391

Historical Rank

Logic

#5111

World Rank

#6475

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Martin G. Zeier's Degrees

Doctorate Medicine University of California, San Francisco
PhD Biomedical Sciences Stanford University

Why Is Martin G. Zeier Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Martin G. Zeier's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary. (2010) (1762)
Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis (2011) (766)
Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis (2007) (371)
KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors (2017) (324)
Glyoxalase‐1 prevents mitochondrial protein modification and enhances lifespan in Caenorhabditis elegans (2008) (266)
C. elegans as Model for the Study of High Glucose– Mediated Life Span Reduction (2009) (245)
European Renal Best Practice Guideline on Kidney Donor and Recipient Evaluation and Perioperative Care (2015) (242)
The effect of donor gender on graft survival. (2002) (238)
Malignancy in renal transplantation. (2004) (222)
Renal functional reserve in healthy elderly subjects. (1993) (219)
Intensive Supportive Care plus Immunosuppression in IgA Nephropathy. (2015) (178)
No improvement of patient or graft survival in transplant recipients treated with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers: a collaborative transplant study report. (2006) (175)
Summary of Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors (2017) (170)
Glucose degradation products in PD fluids: do they disappear from the peritoneal cavity and enter the systemic circulation? (2003) (165)
Renal histology in polycystic kidney disease with incipient and advanced renal failure. (1992) (155)
A tripartite complex of suPAR, APOL1 risk variants and αvβ3 integrin on podocytes mediates chronic kidney disease (2017) (146)
ABO-Incompatible Kidney Transplantation (2017) (145)
Wound complications following kidney and liver transplantation (2006) (143)
New Ecological Aspects of Hantavirus Infection: A Change of A Paradigm and a Challenge of Prevention- A Review (2005) (138)
Arteriolar wall thickening, capillary rarefaction and interstitial fibrosis in the heart of rats with renal failure:the effects of ramipril, nifedipine and moxonidine. (1996) (135)
Three-Year Outcomes Following 1420 ABO-Incompatible Living-Donor Kidney Transplants Performed After ABO Antibody Reduction: Results From 101 Centers (2015) (132)
Sustained low efficiency dialysis using a single-pass batch system in acute kidney injury - a randomized interventional trial: the REnal Replacement Therapy Study in Intensive Care Unit PatiEnts (2012) (129)
Metabolic control improves long-term renal allograft and patient survival in type 1 diabetes. (2008) (129)
CYP3A5 genotype is not associated with a higher risk of acute rejection in tacrolimus-treated renal transplant recipients (2008) (126)
Hantavirus Causing Hemorrhagic Fever with Renal Syndrome Enters from the Apical Surface and Requires Decay-Accelerating Factor (DAF/CD55) (2008) (126)
The German Chronic Kidney Disease (GCKD) study: design and methods. (2012) (123)
Damage to the peritoneal membrane by glucose degradation products is mediated by the receptor for advanced glycation end-products. (2005) (121)
Is gender a determinant for evolution of renal failure? A study in autosomal dominant polycystic kidney disease. (1989) (119)
Effects of donor pretreatment with dopamine on graft function after kidney transplantation: a randomized controlled trial. (2009) (119)
Sirolimus in renal transplantation. (2007) (117)
A Report of the Lisbon Conference on the Care of the Kidney Transplant Recipient (2007) (114)
Pregnancy‐associated diseases are characterized by the composition of the systemic regulatory T cell (Treg) pool with distinct subsets of Tregs (2012) (113)
Cardiac biomarkers and survival in haemodialysis patients (2007) (110)
Aortic changes in experimental renal failure: hyperplasia or hypertrophy of smooth muscle cells? (1997) (107)
Hantavirus infection: an emerging infectious disease causing acute renal failure. (2013) (101)
Malignancy after renal transplantation. (2002) (99)
Antifibrotic actions of mycophenolic acid (2006) (98)
Real‐Time Contrast‐Enhanced Sonography of Renal Transplant Recipients Predicts Chronic Allograft Nephropathy (2006) (95)
Elevated blood pressure profile and left ventricular mass in children and young adults with autosomal dominant polycystic kidney disease. (1993) (95)
Effect of ramipril, nifedipine, and moxonidine on glomerular morphology and podocyte structure in experimental renal failure. (1996) (93)
Increased infarct size in uremic rats: reduced ischemia tolerance? (2004) (92)
Monitoring of NFAT-regulated gene expression in the peripheral blood of allograft recipients: a novel perspective toward individually optimized drug doses of cyclosporine A (2004) (92)
Influence of Test Technique on Sensitization Status of Patients on the Kidney Transplant Waiting List (2013) (92)
Intercellular Communication by Exchange of Cytoplasmic Material via Tunneling Nano-Tube Like Structures in Primary Human Renal Epithelial Cells (2011) (91)
Pharmacodynamic Monitoring of Cyclosporine A in Renal Allograft Recipients Shows a Quantitative Relationship Between Immunosuppression and the Occurrence of Recurrent Infections and Malignancies (2006) (89)
Late referral--a major cause of poor outcome in the very elderly dialysis patient. (2006) (88)
Adult dominant polycystic kidney disease--clinical problems. (1988) (85)
Aquaporin-1 Channel Function Is Positively Regulated by Protein Kinase C* (2007) (81)
Epidemiological Approach to Identifying Genetic Predispositions for Atypical Hemolytic Uremic Syndrome (2010) (80)
Molecular mechanisms of the antiangiogenic and antitumor effects of mycophenolic acid (2008) (78)
Early Humoral Responses of Hemodialysis Patients after COVID-19 Vaccination with BNT162b2 (2021) (77)
Thymoglobulin and ischemia reperfusion injury in kidney and liver transplantation. (2007) (75)
Association of Kidney Graft Loss With De Novo Produced Donor-Specific and Non-Donor-Specific HLA Antibodies Detected by Single Antigen Testing (2015) (74)
Is diabetes an acquired disorder of reactive glucose metabolites and their intermediates? (2012) (74)
Seroprevalence of hantavirus antibodies in Germany as determined by a new recombinant enzyme immunoassay (1995) (73)
Ciclosporin A Tapering Monitored by NFAT-Regulated Gene Expression: A New Concept of Individual Immunosuppression (2008) (70)
Renal sympathetic denervation therapy in the real world: results from the Heidelberg registry (2014) (67)
Pathogenic Old World Hantaviruses Infect Renal Glomerular and Tubular Cells and Induce Disassembling of Cell-to-Cell Contacts (2011) (67)
A distinct subset of HLA-DR+-regulatory T cells is involved in the induction of preterm labor during pregnancy and in the induction of organ rejection after transplantation. (2010) (67)
High‐dose melphalan with autologous stem cell transplantation after VAD induction chemotherapy for treatment of amyloid light chain amyloidosis: a single centre prospective phase II study (2004) (66)
Do AV Fistulas Contribute to Cardiac Mortality in Hemodialysis Patients? (2002) (63)
Unusual spindle cell squamous carcinoma in a renal transplant patient. (2004) (61)
After ten years of follow-up, no difference between supportive care plus immunosuppression and supportive care alone in IgA nephropathy. (2020) (61)
Assessment of renal allograft fibrosis by transient elastography (2013) (60)
Kidney and hypertension. (2002) (60)
Efficacy comparison of intravenous and subcutaneous recombinant human erythropoietin administration in hemodialysis patients. (1991) (60)
Transplant-associated thrombotic microangiopathy is an endothelial complication associated with refractoriness of acute GvHD (2017) (59)
Pharmacokinetic and pharmacodynamic analysis of enteric-coated mycophenolate sodium: limited sampling strategies and clinical outcome in renal transplant patients. (2010) (58)
ABO-Incompatible Kidney Transplantation Enabled by Non-Antigen-Specific Immunoadsorption (2012) (57)
Color Doppler Indices of Renal Allografts Depend on Vascular Stiffness of the Transplant Recipients (2006) (57)
Effects of Two Immunosuppressive Treatment Protocols for IgA Nephropathy. (2017) (56)
Sporadic cases of acute autochthonous hepatitis E virus infection in Southwest Germany. (2010) (56)
Switch of immunosuppression from cyclosporine A to everolimus: impact on pulse wave velocity in stable de-novo renal allograft recipients (2008) (55)
Living donor kidney transplantation in crossmatch‐positive patients enabled by peritransplant immunoadsorption and anti‐CD20 therapy (2012) (55)
An Integrative Approach for the Transplantation of High-Risk Sensitized Patients (2010) (55)
Transplantation of the type 1 diabetic patient: the long-term benefit of a functioning pancreas allograft. (2010) (55)
Homeostatic nuclear RAGE–ATM interaction is essential for efficient DNA repair (2017) (53)
Hypertension in the Transplanted Patient (1998) (52)
Comparison of the laparoscopic versus open live donor nephrectomy: an overview of surgical complications and outcome (2014) (51)
Pharmacodynamic monitoring of calcineurin inhibitor therapy: is there a clinical benefit? (2008) (50)
Anti‐chromatin and anti‐C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases (2007) (50)
The first 5 years of the family clinic for HIV at Tygerberg Hospital: family demographics, survival of children and early impact of antiretroviral therapy. (2006) (50)
Proteinuria after renal transplantation: pathogenesis and management. (2004) (49)
Proton pump inhibitors interfere with the immunosuppressive potency of mycophenolate mofetil. (2010) (49)
Calcineurin inhibitors and NFAT-regulated gene expression. (2012) (48)
No regression of renal AL amyloid in monoclonal gammopathy after successful autologous blood stem cell transplantation and significant clinical improvement. (2003) (48)
Analysis of NFAT-regulated gene expression in vivo: a novel perspective for optimal individualized doses of calcineurin inhibitors. (2004) (47)
The long-term consequences of living-related or unrelated kidney donation. (2004) (47)
Benfotiamine protects against peritoneal and kidney damage in peritoneal dialysis. (2011) (47)
Cardiovascular mortality of patients with polycystic kidney disease on dialysis: is there a lesson to learn? (1994) (46)
Individualized Monitoring of Nuclear Factor of Activated T Cells-Regulated Gene Expression in FK506-Treated Kidney Transplant Recipients (2010) (46)
Hantavirus infection. (2005) (45)
Cardiac biomarkers are influenced by dialysis characteristics. (2007) (45)
AcylMPAG Plasma Concentrations and Mycophenolic Acid-Related Side Effects in Patients Undergoing Renal Transplantation Are Not Related to the UGT2B7-840G>A Gene Polymorphism (2008) (45)
Pharmacodynamic immune monitoring of NFAT‐regulated genes predicts skin cancer in elderly long‐term renal transplant recipients (2008) (45)
Pharmacokinetics and pharmacodynamics of intensified versus standard dosing of mycophenolate sodium in renal transplant patients. (2010) (45)
Effect of paricalcitol and calcitriol on aortic wall remodeling in uninephrectomized ApoE knockout mice. (2011) (45)
Living‐donor kidney transplantation: risks of the donor – benefits of the recipient (2006) (45)
Effects of Dopamine Donor Pretreatment on Graft Survival after Kidney Transplantation: A Randomized Trial. (2017) (44)
Urinary miR‐155‐5p and CXCL10 as prognostic and predictive biomarkers of rejection, graft outcome and treatment response in kidney transplantation (2017) (44)
Heterologous ChAdOx1 nCoV-19/BNT162b2 Prime-Boost Vaccination Induces Strong Humoral Responses among Health Care Workers (2021) (44)
Peritoneal dialysis as therapeutic option in heart failure patients (2019) (44)
Immunogenicity and efficacy in hemodialysis patients of an AS03(A)-adjuvanted vaccine for 2009 pandemic influenza A(H1N1): a nonrandomized trial. (2011) (43)
The outcome of autologous stem cell transplantation in patients with plasma cell disorders and dialysis-dependent renal failure. (2006) (43)
The role and value of sirolimus administration in kidney and liver transplantation (2006) (43)
DRhigh+CD45RA−-Tregs Potentially Affect the Suppressive Activity of the Total Treg Pool in Renal Transplant Patients (2012) (43)
Review of the antiproliferative properties of mycophenolate mofetil in non-immune cells. (2003) (43)
Plasma exchange in critically ill COVID-19 patients (2020) (43)
Outcomes Following ABO-Incompatible Kidney Transplantation Performed After Desensitization by Nonantigen-Specific Immunoadsorption (2015) (42)
The spectrum of renal involvement in epidermolysis bullosa dystrophica hereditaria: report of two cases. (1988) (41)
Do we need screening for thrombophilia prior to kidney transplantation? (2004) (41)
Renal toxicity mediated by glucose degradation products in a rat model of advanced renal failure (2008) (40)
Clinical Relevance of HLA Antibody Monitoring after Kidney Transplantation (2014) (39)
Posttransplant sCD30 as a Predictor of Kidney Graft Outcome (2011) (38)
RAGE expression in the human peritoneal membrane. (2008) (38)
Congestive Heart Failure Due to Systolic Dysfunction: The Cinderella of Cardiovascular Management in Dialysis Patients (2002) (37)
Anticipation of age at renal death in autosomal dominant polycystic kidney disease (ADPKD)? (1995) (37)
A tripartite complex of suPAR, APOL1 risk variants and alpha(v)beta(3) integrin on podocytes mediates chronic kidney disease (37)
Pharmacodynamic Monitoring of Cyclosporin A Reveals Risk of Opportunistic Infections and Malignancies in Renal Transplant Recipients 65 Years and Older (2011) (37)
Pharmacodynamic cyclosporine A‐monitoring: relation of gene expression in lymphocytes to cyclosporine blood levels in cardiac allograft recipients (2007) (37)
Calcineurin inhibitor sparing regimens using m‐target of rapamycin inhibitors: an opportunity to improve cardiovascular risk following kidney transplantation? (2011) (37)
Effects of Peritoneal Dialysis Solutions Low in GDPs on Peritonitis and Exit-Site Infection Rates (2008) (37)
Hypertension after renal transplantation (2001) (36)
Differentiation of ICOS+ and ICOS− recent thymic emigrant regulatory T cells (RTE Tregs) during normal pregnancy, pre‐eclampsia and HELLP syndrome (2016) (36)
Donor preconditioning with taurine protects kidney grafts from injury after experimental transplantation. (2008) (36)
Overhydration Is a Strong Predictor of Mortality in Peritoneal Dialysis Patients – Independently of Cardiac Failure (2016) (35)
Whole Blood Transcriptomics in Cardiac Surgery Identifies a Gene Regulatory Network Connecting Ischemia Reperfusion with Systemic Inflammation (2010) (35)
[Incidence and clinical characteristics of renal insufficiency in diabetic patients]. (2001) (35)
Borderline rejection after renal transplantation – to treat or not to treat (2009) (35)
Risk of Mortality in Patients with End-Stage Renal Disease: The Role of Malnutrition and Possible Therapeutic Implications (2002) (35)
Effects of testosterone on glomerular growth after uninephrectomy. (1998) (35)
Longitudinal Humoral Responses after COVID-19 Vaccination in Peritoneal and Hemodialysis Patients over Twelve Weeks (2021) (34)
Impact of Intraoperative Parathyroid Hormone Levels on Surgical Results in Patients with Renal Hyperparathyroidism (2005) (34)
Age‐Related Penetrance of Hereditary Atypical Hemolytic Uremic Syndrome (2011) (34)
Simultaneous pancreas–kidney transplantation in type 1 diabetes (2004) (34)
Safe Administration of An Anti-PD-1 Antibody to Kidney-transplant Patients: 2 Clinical Cases and Review of the Literature. (2017) (33)
Nanotube Action between Human Mesothelial Cells Reveals Novel Aspects of Inflammatory Responses (2011) (33)
Immunosuppressive therapy and post-transplant malignancy. (2008) (33)
IVIM-DWI of transplanted kidneys: reduced diffusion and perfusion dependent on cold ischemia time. (2012) (33)
Role of podocytes in lupus nephritis. (2009) (33)
Protocol biopsy: what is the rationale and what is the evidence? (2003) (33)
Transmission of Malignancy with Solid Organ Transplants (2005) (33)
The influence of immunosuppression on the development of BK virus nephropathy-- does it matter? (2007) (32)
Everolimus with cyclosporine withdrawal or low-exposure cyclosporine in kidney transplantation from Month 3: a multicentre, randomized trial (2017) (31)
suPAR and chronic kidney disease—a podocyte story (2017) (31)
Four cases of sirolimus-associated interstitial pneumonitis: identification of risk factors. (2007) (31)
Cyclosporin A Toxicity of the Renal Allograft – a Late Complication and Potentially Reversible (2002) (31)
Effects of Mycophenolic Acid on Human Fibroblast Proliferation, Migration and Adhesion In Vitro and In Vivo (2008) (31)
Methylprednisolone treatment increases the proportion of the highly suppressive HLA-DR(+)-Treg-cells in transplanted patients. (2012) (30)
Prevention and management of lymphocele formation following kidney transplantation. (2017) (30)
Successful treatment of chronic tophaceous gout with infliximab (Remicade) (2005) (30)
Advanced glycation endproducts (AGEs) as uremic toxins. (2001) (30)
GLUCOSE DEGRADATION PRODUCTS RESULT IN CARDIOVASCULAR TOXICITY IN A RAT MODEL OF RENAL FAILURE (2010) (29)
Management of severe recurrent focal segmental glomerulosclerosis through circulating soluble urokinase receptor modification. (2013) (29)
Contrast-enhanced ultrasonography in the early period after kidney transplantation predicts long-term allograft function. (2014) (29)
Results of renal transplantation using kidneys harvested from living donors at the University of Heidelberg. (2004) (29)
Immunomonitoring of nuclear factor of activated T cells–regulated gene expression: The first clinical trial in liver allograft recipients (2011) (29)
Hemophagocytic lymphohistiocytosis in an adult kidney transplant recipient successfully treated by plasmapheresis (2017) (28)
When is contrast-enhanced sonography preferable over conventional ultrasound combined with Doppler imaging in renal transplantation? (2015) (28)
Effect of insulin and glucose infusion on myocardial infarction size in uraemic rats (2009) (28)
Color Doppler Ultrasonography in the Diagnostic Evaluation of Renal Allografts (2006) (28)
Real‐time contrast‐enhanced sonography in renal transplant recipients (2006) (28)
The role of recent thymic emigrant‐regulatory T‐cell (RTE‐Treg) differentiation during pregnancy (2015) (27)
The success of assisted reproduction technologies in relation to composition of the total regulatory T cell (Treg) pool and different Treg subsets. (2013) (27)
End‐stage renal disease, dialysis, kidney transplantation and their impact on CD4+ T‐cell differentiation (2018) (27)
Rosiglitazone reduces angiotensin II and advanced glycation end product-dependent sustained nuclear factor-kappaB activation in cultured human proximal tubular epithelial cells. (2008) (27)
More adverse renal prognosis of autosomal dominant polycystic kidney disease in families with primary hypertension. (1995) (27)
Safety and Efficacy of Intensified Versus Standard Dosing Regimens of Enteric-Coated Mycophenolate Sodium in De Novo Renal Transplant Patients (2011) (27)
A single center experience of combined liver kidney transplantation (2009) (27)
Role of FTY720 on M1 and M2 macrophages, lymphocytes, and chemokines in 5/6 nephrectomized rats. (2009) (27)
Clinical Manifestation and Management of ADPKD in Western Countries (2016) (26)
Prevention of antibody‐mediated kidney transplant rejection (2012) (26)
Dysregulated Cytokine Responses During Cytomegalovirus Infection in Renal Transplant Recipients (2008) (26)
Pharmacodynamic Disparities in Tacrolimus-Treated Patients Developing Cytomegalus Virus Viremia (2011) (26)
Psychosocial and physical outcome following kidney donation—a retrospective analysis (2015) (25)
Neutralizing antibody response against the B.1.617.2 (delta) and the B.1.1.529 (omicron) variants after a third mRNA SARS-CoV-2 vaccine dose in kidney transplant recipients (2022) (25)
Issues of Acute Kidney Injury Staging and Management in Sepsis and Critical Illness: A Narrative Review (2017) (25)
Urinary Proinflammatory Cytokine Response in Renal Transplant Recipients With Polyomavirus BK Viruria (2009) (25)
Monitoring immunosuppression with measures of NFAT decreases cancer incidence. (2009) (25)
The effect of uninephrectomy on progression of renal failure in autosomal dominant polycystic kidney disease. (1992) (25)
European renal best practice guideline on the management and evaluation of the kidney donor and recipient. (2014) (25)
Living donor kidney transplantation in patients with donor-specific HLA antibodies enabled by anti-CD20 therapy and peritransplant apheresis. (2013) (24)
Efficacy and safety of enteric-coated mycophenolate sodium in de novo renal transplant recipients: pooled data from three 12-month multicenter, open-label, prospective studies. (2007) (24)
Long-term treatment of central Cushing's syndrome with rosiglitazone. (2007) (24)
Glycaemic control and antidiabetic therapy in patients with diabetes mellitus and chronic kidney disease – cross-sectional data from the German Chronic Kidney Disease (GCKD) cohort (2016) (24)
Mutations in the BC‐loop of the BKV VP1 region do not influence viral load in renal transplant patients (2009) (24)
Phase-I trial of donor-derived modified immune cell infusion in kidney transplantation. (2020) (24)
Bowel Perforation with Unused Tenckhoff Catheters (1989) (24)
Applicability of robot-assisted laparoscopic radical prostatectomy in renal allograft recipients. (2012) (23)
Non-occlusive mesenteric infarction in dialysis patients: the importance of prevention and early intervention. (1995) (23)
Clinical Relevance of HLA Antibodies in Kidney Transplantation: Recent Data from the Heidelberg Transplant Center and the Collaborative Transplant Study (2017) (23)
Hantavirus infection--haemorrhagic fever in the Balkans--potential nephrological hazards in the Kosovo war. (1999) (23)
Genetic polymorphisms in IL‐2, IL‐10, TGF‐β1, and IL‐2RB and acute rejection in renal transplant patients (2014) (23)
Cellular Effects of Everolimus and Sirolimus on Podocytes (2013) (23)
The role of an interdisciplinary transplant team on living donation kidney transplantation program. (2010) (23)
Renal function and renal disease in males or females--vive la petite difference. (1998) (22)
The role of pretransplant dialysis modality on renal allograft outcome. (2011) (22)
Cardiac Biomarkers in Haemodialysis Patients: The Prognostic Value of Amino-Terminal Pro-B-Type Natriuretic Peptide and Cardiac Troponin T (2007) (22)
Clostridium difficile diarrhoea in the immunosuppressed patient--update on prevention and management. (2004) (22)
Renal Function in Type 2 Diabetes Following Gastric Bypass. (2016) (22)
Expanding the Indications of Pancreas Transplantation Alone (2014) (22)
Pharmacodynamic monitoring of cyclosporine A by NFAT‐regulated gene expression and the relationship with infectious complications in pediatric renal transplant recipients (2010) (21)
Autosomal dominant polycystic kidney disease--the patient on renal replacement therapy. (1996) (21)
Desensitization strategies enabling successful renal transplantation in highly sensitized patients (2006) (21)
An oral load of the early glycation compound lactuloselysine fails to accumulate in the serum of uraemic patients. (2006) (21)
Uremia Aggravates Left Ventricular Remodeling after Myocardial Infarction (2010) (21)
Contrast Enhanced Sonography Shows Superior Microvascular Renal Allograft Perfusion in Patients Switched From Cyclosporine A to Everolimus (2009) (21)
Pathophysiology of cardiovascular disease and renal failure. (2005) (21)
Donor-specific antibodies require preactivated immune system to harm renal transplant (2016) (21)
Human RAGE antibody protects against AGE-mediated podocyte dysfunction. (2012) (21)
Evidence for IFN‐γ up‐ and IL‐4 downregulation late post‐transplant in patients with good kidney graft outcome (2007) (21)
Genesis and significance of hypertension in autosomal dominant polycystic kidney disease. (1994) (20)
Mobilization of Circulating Endothelial Progenitor Cells Correlates with the Clinical Course of Hantavirus Disease (2013) (20)
Cellular Infiltrates and NF&kgr;B Subunit c-Rel Signaling in Kidney Allografts of Patients With Clinical Operational Tolerance (2012) (20)
Sodium citrate anticoagulation during sustained low efficiency dialysis (SLED) in patients with acute renal failure and severely impaired liver function. (2007) (20)
Successful Deceased-Donor Kidney Transplantation in Crossmatch-Positive Patients With Peritransplant Plasma Exchange and Rituximab (2009) (20)
In Renal Transplants With Delayed Graft Function Chemokines and Chemokine Receptor Expression Predict Long-Term Allograft Function (2010) (20)
Disorders of phosphate metabolism--pathomechanisms and management of hypophosphataemic disorders. (2003) (20)
Tailoring of alerts substantially reduces the alert burden in computerized clinical decision support for drugs that should be avoided in patients with renal disease (2015) (20)
Progression of renal failure in the Han: SPRD polycystic kidney rat. (1994) (20)
Procalcitonin as marker of infection in patients with Goodpasture's syndrome is misleading. (2007) (19)
ABO-incompatible transplantation--a safe way to perform renal transplantation? (2006) (19)
Targeting the Retinoblastoma Protein by MC007L, Gene Product of the Molluscum Contagiosum Virus: Detection of a Novel Virus-Cell Interaction by a Member of the Poxviruses (2008) (19)
Enteric-coated mycophenolate sodium immunosuppression in renal transplant patients: efficacy and dosing. (2012) (19)
Ambulatory blood pressure monitoring: fancy gadgetry or clinically useful exercise? (2001) (19)
Plasmapheresis Adjusts Inflammatory Responses in Potential Kidney Transplant Recipients (2013) (19)
Indications for High-Dose Chemotherapy with Autologous Stem Cell Support in Patients with Systemic Amyloid Light Chain Amyloidosis (2005) (19)
Kidney and Hypertension—Causes (2003) (18)
Cell Cycle Biomarkers and Soluble Urokinase-Type Plasminogen Activator Receptor for the Prediction of Sepsis-Induced Acute Kidney Injury Requiring Renal Replacement Therapy: A Prospective, Exploratory Study (2019) (18)
Immunosuppressive standards in simultaneous kidney–pancreas transplantation (2006) (18)
Does Borderline Kidney Allograft Rejection Always Require Treatment? (2010) (18)
No gender-related differences in the severity of nephropathia epidemica, Germany (2013) (18)
Peritoneal ultrafiltration in end-stage chronic heart failure (2015) (18)
Preparation of the dialysis patient for transplantation. (2002) (18)
Acute Effects of Calcineurin Inhibitors on Kidney Allograft Microperfusion Visualized by Contrast-Enhanced Sonography (2012) (18)
Strong association of phenylalanine and tryptophan metabolites with activated cytomegalovirus infection in kidney transplant recipients. (2012) (18)
Role of infection in the genesis of acute renal failure. (1994) (17)
Non-Occlusive Mesenteric Infarction (NOMI) in Dialysis Patients - Risk Factors, Diagnosis, Intervention and Outcome (1992) (17)
Reduced-exposure cyclosporine is safe and efficacious in de novo renal transplant recipients treated with enteric-coated mycophenolic acid and basiliximab. (2007) (17)
Neutralizing antibody response against variants of concern after vaccination of dialysis patients with BNT162b2 (2021) (17)
Transmission of donor-derived small-cell carcinoma cells by a nontumor-bearing allograft. (2005) (17)
Severe hemorrhagic complications from infection with nephropathia epidemica strain of Hantavirus. (1992) (17)
Atherosclerotic complications after renal transplantation (2000) (17)
Old World hantaviruses: aspects of pathogenesis and clinical course of acute renal failure. (2014) (17)
Deciphering the systems biology of mTOR inhibition by integrative transcriptome analysis. (2014) (17)
Soluble Urokinase Plasminogen Activator Receptor and Decline in Kidney Function in Autosomal Dominant Polycystic Kidney Disease. (2019) (17)
Kidney transplantation for high-risk sensitized patients - the "Heidelberg algorithm". (2011) (16)
The extent of HLA‐DR expression on HLA‐DR+ Tregs allows the identification of patients with clinically relevant borderline rejection (2013) (16)
Bortezomib improves outcome after SCT in multiple myeloma patients with end-stage renal failure (2014) (16)
New concepts to individualize calcineurin inhibitor therapy in renal allograft recipients. (2010) (16)
Blood pressure profile and treatment quality in liver allograft recipients-benefit of tacrolimus versus cyclosporine. (2004) (16)
The impact of type 2 diabetes on the outcome of localized renal cell carcinoma (2013) (16)
Chronic low-dose isotretinoin treatment limits renal damage in subtotally nephrectomized rats (2008) (16)
Neutralization of SARS-CoV-2 Variants of Concern in Kidney Transplant Recipients after Standard COVID-19 Vaccination (2021) (16)
Targeting Activation of Specific NF-κB Subunits Prevents Stress-Dependent Atherothrombotic Gene Expression (2012) (15)
Acute phase reaction to gadolinium-DTPA in dialysis patients. (2008) (15)
Comprehensive immunohistological analysis of the endothelin system in human kidney grafts. (2006) (15)
Absence of mismatch repair deficiency-related microsatellite instability in non-melanoma skin cancer. (2012) (15)
Correction: Sustained low efficiency dialysis using a single-pass batch system in acute kidney injury - a randomized interventional trial: the REnal Replacement Therapy Study in Intensive Care Unit PatiEnts (2012) (15)
Pre‐transplant soluble CD30 in combination with total DSA but not pre‐transplant C1q‐DSA predicts antibody‐mediated graft loss in presensitized high‐risk kidney transplant recipients (2016) (15)
Third COVID-19 vaccine dose with BNT162b2 in patients with ANCA-associated vasculitis (2022) (15)
Benefits of peritoneal ultrafiltration in HFpEF and HFrEF patients (2020) (14)
Cell therapeutic approaches to immunosuppression after clinical kidney transplantation (2018) (14)
Lymphoid interstitial lung disease in a patient with acute tubulointerstitial nephritis and uveitis: a new facet of a rare syndrome? (2006) (14)
Acrorenal syndrome in an adult--presentation with proteinuria, hypertension, and glomerular lesions. (1989) (14)
Kidney transplantation in highly sensitized patients: are there options to overcome a positive crossmatch? (2011) (13)
AEB071 – a promising immunosuppressive agent (2009) (13)
Assessment of renal function in routine care of people living with HIV on ART in a resource-limited setting in urban Zambia (2017) (13)
Onset and progression of diabetes in kidney transplant patients receiving everolimus or cyclosporine therapy: an analysis of two randomized, multicenter trials (2018) (13)
Decreasing plasma soluble IL‐1 receptor antagonist and increasing monocyte activation early post‐transplant may be involved in pathogenesis of delayed graft function in renal transplant recipients (2009) (13)
Henoch-Schönlein purpura in adults is not uncommon in elderly patients with an adverse prognosis. (2011) (13)
The arrhythmogenic face of COVID-19: Brugada ECG pattern during acute infection (2020) (13)
Outcomes and complications following ABO‐incompatible kidney transplantation performed after desensitization by semi‐selective immunoadsorption ‐ a retrospective study (2019) (13)
Treatment of gross hematuria in autosomal dominant polycystic kidney disease with aprotinin and desmopressin acetate. (1992) (13)
Dual regulation of renal Kir7.1 potassium channels by protein Kinase A and protein Kinase C. (2008) (13)
The Calcineurin Inhibitor-Sparing (CIS) Trial - individualised calcineurin-inhibitor treatment by immunomonitoring in renal allograft recipients: protocol for a randomised controlled trial (2014) (13)
Motility of human renal cells is disturbed by infection with pathogenic hantaviruses (2018) (13)
Switch to an everolimus‐facilitated cyclosporine A sparing immunosuppression improves glycemic control in selected kidney transplant recipients (2017) (12)
Influence of Blood Pressure and Calcineurin Inhibitors on Kidney Function After Heart or Liver Transplantation (2017) (12)
[Acute kidney failure caused by Hantaan virus. Case report from the West Germany]. (2008) (12)
Treatment of Life-Threatening Multiresistant Staphylococcal and Enterococcal Infections in Patients with End-Stage Renal Failure with Quinupristin/Dalfopristin: Preliminary Report (2002) (12)
Donor organ intervention before kidney transplantation: Head‐to‐head comparison of therapeutic hypothermia, machine perfusion, and donor dopamine pretreatment. What is the evidence? (2019) (12)
The receptor for advanced glycation end-products (RAGE) plays a key role in the formation of nanotubes (NTs) between peritoneal mesothelial cells and in murine kidneys (2014) (12)
Neutralizing Antibody Activity Against the B.1.617.2 (delta) Variant Before and After a Third BNT162b2 Vaccine Dose in Hemodialysis Patients (2022) (12)
Bovine aortic endothelial cells are susceptible to hantavirus infection; a new aspect in hantavirus ecology. (2004) (12)
Recent outbreaks of hantavirus disease in Germany and in the United States. (2012) (12)
[Uremic patients--late referral, early death]. (2003) (12)
Approaches towards Individualized Immune Intervention (2010) (12)
Impact of Surgeon's Experience on Vascular and Haemorrhagic Complications After Kidney Transplantation. (2019) (12)
Interdisciplinary counseling service for renal malignancies: a patient-centered approach to raise guideline adherence. (2015) (12)
[The clinical significance of renal cell carcinoma in dialysis dependent patients in comparison with kidney transplant recipients]. (1997) (11)
Hypertension in the transplanted patient. (1998) (11)
Underdiagnosis of diabetes mellitus in chronic dialysis patients on the renal transplant waiting list. (2003) (11)
Consensus on definition and severity grading of lymphatic complications after kidney transplantation (2020) (11)
Hypertension after renal transplantation. (2001) (11)
Evolution of allograft fibrosis and function in kidney transplant recipients: a retrospective analysis of stable patients under CNI and mTORi (2015) (11)
Transplantation in type 1 diabetes. (2009) (11)
Angiotensin‐converting enzyme inhibitors and angiotensin II type 1 receptor blockers after renal transplantation (2009) (11)
High interpatient variability in response to mycophenolic acid maintenance therapy in patients with ANCA-associated vasculitis. (2015) (11)
Serum uromodulin and Roux-en-Y gastric bypass: improvement of a marker reflecting nephron mass. (2019) (11)
Long-Term Follow-Up of Kidney Transplant Recipients With Polycystic Kidney Disease. (2015) (11)
IL-23 plasma level is strongly associated with CMV status and reactivation of CMV in renal transplant recipients (2016) (11)
SICCA SYNDROME IN PATIENTS WITH WEGENER'S GRANULOMATOSIS (1989) (11)
Cyclosporine-induced gingival overgrowth correlates with NFAT-regulated gene expression: a pilot study. (2011) (11)
Correlation between pharmacokinetics of tacrolimus and pharmacodynamics on NFAT-regulated gene expression in stable kidney transplant recipients . (2017) (11)
Improved Rejection Prophylaxis With an Initially Intensified Dosing Regimen of Enteric-Coated Mycophenolate Sodium in De Novo Renal Transplant Recipients (2011) (11)
Clinical characterization of two severe cases of hemorrhagic fever with renal syndrome (HFRS) caused by hantaviruses Puumala and Dobrava-Belgrade genotype Sochi (2016) (11)
Relevance of donor‐specific antibody monitoring after kidney transplantation: Findings from the Collaborative Transplant Study and the Heidelberg Transplant Center (2019) (11)
Monitoring of calcineurin inhibitors by NFAT-regulated gene expression in de novo renal allograft recipients on cyclosporine A. (2015) (11)
Should kidney allografts from old donors be allocated only to old recipients? (2020) (10)
The Case: Renal failure in a male with Waldenström's macroglobulinemia. (2010) (10)
Neutralizing antibody activity against the B.1.617.2 (delta) variant 8 months after two-dose vaccination with BNT162b2 in health care workers (2022) (10)
When should post-transplantation proteinuria be attributed to the renal allograft rather than to the native kidney? (2007) (10)
A Single-center Experience on the Value of Pancreas Graft Biopsies and HLA Antibody Monitoring After Simultaneous Pancreas-Kidney Transplantation. (2015) (10)
Rheumatoid Arthritis and the Kidney: Uneasy Companions (2004) (10)
Acquired Glanzmann´s thrombasthenia variant and immune thrombocytopenia in a renal transplant recipient receiving tacrolimus (2005) (10)
Evaluation of Hepatocyte Growth Factor as a Sensitive Marker for Early Detection of Acute Renal Allograft Rejection (2007) (10)
Epstein-Barr Virus Induces Expression of the LPAM-1 Integrin in B Cells In Vitro and In Vivo (2018) (10)
Recovery of renal function after delayed percutaneous dilation of a subtotal in-stent restenosis of the renal artery in a left solitary kidney (2009) (10)
Status of periodontal health in German patients suffering from chronic kidney disease - Data from GCKD study. (2019) (10)
Humoral Responses to Single-Dose BNT162b2 mRNA Vaccination in Dialysis Patients Previously Infected With SARS-CoV-2 (2021) (10)
Early conversion from cyclosporine to everolimus following living-donor kidney transplantation: outcomes at 5 years posttransplant in the randomized ZEUS trial. (2016) (9)
Effect of ACE inhibitors, calcium channel blockers and their combination on renal and extrarenal structures in renal failure. (1995) (9)
Clinical Impact of Hepatitis C Virus Infection in the Renal Transplant Recipient (2002) (9)
Efficacy and safety of conversion from cyclosporine to everolimus in living‐donor kidney transplant recipients: an analysis from the ZEUS study (2014) (9)
Cytomegalovirus infection of the major duodenal papilla in a renal allograft recipient with severe biliary obstruction and acalculous cholecystitis (2013) (9)
Clinical nephrology in 19th century Germany. (1994) (9)
[Integrated skills laboratory concept for undergraduate training in internal medicine]. (2005) (9)
French and German nephrologists in the mid-19th century. The impact of Richard Bright on the continent. (1989) (9)
Virus- and cell type-specific effects in orthohantavirus infection. (2019) (9)
Use of erythropoietin after solid organ transplantation. (2007) (9)
The living kidney donor: giving life, avoiding harm. (2003) (9)
Characterization of a new Puumala virus genotype associated with hemorrhagic fever with renal syndrome (2006) (9)
Recent developments in desensitization of crossmatch-positive kidney transplant recipients. (2012) (8)
Response to A reassessment of the Survival Advantage of Simultaneous Kidney-Pancreas Versus Kidney-Alone Transplantation. (2015) (8)
The possible critical role of T‐cell help in DSA‐mediated graft loss (2018) (8)
Effect of mycophenolic acid on inosine monophosphate dehydrogenase (IMPDH) activity in liver transplant patients. (2020) (8)
Plasma Exchange in Patients With Severe Coronavirus Disease 2019: A Single-Center Experience (2021) (8)
European Renal Best Practice Guideline on Kidney Donor and Recipient Evaluation and Perioperative Care (2015) (8)
Bovine aortic endothelial cells are susceptible to Hantaan virus infection. (2004) (8)
[Increase in the number of cases of epidemic nephropathy in Germany. Virological and ecological aspects]. (2008) (8)
[The clinical picture and therapy of Hantaan virus infection]. (1990) (8)
Aberrant ICOS+‐T cell differentiation in women with spontaneous preterm labor (2016) (8)
Improved Pulse Wave Velocity and Renal Function in Individualized Calcineurin Inhibitor Treatment by Immunomonitoring: The Randomized Controlled Calcineurin Inhibitor-Sparing Trial (2017) (7)
Antihypertensive Therapy in Renal Patients – Benefits and Difficulties (1999) (7)
C. elegans as model for the study of high glucose mediated lifespan reduction Running title: Glucose regulates lifespan in C. elegans (2009) (7)
The Role of Pre-Procurement Pancreas Suitability Score (P-PASS) and Pancreas Donor Risk Index (PDRI) in the Outcome of Simultaneous Pancreas and Kidney or Pancreas After Kidney Transplantation (2019) (7)
Immunosuppressive therapy influences the accelerated age-dependent T-helper cell differentiation in systemic lupus erythematosus remission patients (2018) (7)
Volumetry may predict early renal function after nephron sparing surgery in solitary kidney patients (2014) (7)
A randomized trial of intensified vs. standard dosing for enteric-coated mycophenolate sodium in de novo kidney transplant recipients: results at 1 year. (2013) (7)
Hantavirus infection--new threats by an old virus. (1998) (7)
Autosomal dominant polycystic kidney disease (ADPKD)--mechanisms of cyst formation and renal failure. (1993) (7)
Blood pressure after renal transplantation. (2001) (7)
Association of Pretransplant Soluble Glycoprotein 130 (sgp130) Plasma Levels and Posttransplant Acute Tubular Necrosis in Renal Transplant Recipients (2009) (7)
Vasogenic Brain Edema During Maintenance Hemodialysis (2019) (7)
Transplantation of a severely lacerated liver – a case report with review of the literature (2009) (7)
[Living-donor kidney transplantation]. (2010) (7)
Deregulation of levels of angiopoietin-1 and angiopoietin-2 is associated with severe courses of hantavirus infection. (2017) (7)
Glomerular filtration barrier dysfunction in a self-limiting, RNA virus-induced glomerulopathy resembles findings in idiopathic nephrotic syndromes (2020) (7)
Effect of Benfotiamine in Podocyte Damage Induced by Peritoneal Dialysis Fluid (2015) (6)
[Primary hyperaldosteronism without arterial hypertension]. (2008) (6)
Gender disparity in health-related quality of life and fatigue after living renal donation (2018) (6)
Analysis of the integrin β3 receptor for pathogenic orthohantaviruses in rodent host species. (2019) (6)
The Epstein–Barr virus DNA load in the peripheral blood of transplant recipients does not accurately reflect the burden of infected cells (2017) (6)
Identification and Cloning of a New Western Epstein-Barr Virus Strain That Efficiently Replicates in Primary B Cells (2020) (6)
Idiopathic interstitial nephritis complicating ulcerative colitis. (1990) (6)
Cell therapy for immunosuppression after kidney transplantation (2015) (6)
Peptide Vaccination against Cytomegalovirus Induces Specific T Cell Response in Responses in CMV Seronegative End-Stage Renal Disease Patients (2021) (6)
Blood pressure on dialysis: an ongoing controversy. (2002) (6)
Renal Artery Stenosis - are there Patients who Benefit from Intervention? (2016) (6)
An update on chemical pharmacotherapy options for the prevention of kidney transplant rejection with a focus on costimulation blockade (2017) (6)
Glucocorticoid maintenance therapy and severe infectious complications in ANCA-associated vasculitis: a retrospective analysis (2020) (6)
The Influence of Gender on the Progression of Renal Failure (1993) (6)
Superior Renal Function in an Everolimus-Based Calcineurin Inhibitor Free Regimen Compared to Standard Cyclosporine/Mycophenolate and Low Cyclosporine/Everolimus: The HERAKLES Study: 1675 (2012) (6)
Pre-transplant HLA Antibodies and Delayed Graft Function in the Current Era of Kidney Transplantation (2020) (6)
Activity of nuclear factor of activated T cells is independent of the number of peripheral lymphocytes in FTY720-treated patients. (2008) (6)
The onset of active disease in systemic lupus erythematosus patients is characterised by excessive regulatory CD4+-T-cell differentiation. (2020) (6)
[Renal replacement therapy in the intensive care unit]. (2006) (5)
Acute Kidney Injury Following High-Dose Vitamin C Treatment. (2019) (5)
The role of age‐related T‐cell differentiation in patients with renal replacement therapy (2017) (5)
Humoral response to SARS-CoV-2 mRNA vaccination in previous non-responder kidney transplant recipients after short-term withdrawal of mycophenolic acid (2022) (5)
Soluble urokinase plasminogen activation receptor and long-term outcomes in persons undergoing coronary angiography (2019) (5)
Life-threatening infection with multiresistantStaphylococcus epidermidis in a patient with end-stage renal disease: Cure with chloramphenicol and quinupristin/dalfopristin (RP 59500) (1997) (5)
[Hantavirus-induced acute renal failure]. (1996) (5)
How Can the Cardiac Death Rate be Reduced in Dialysis Patients? (2002) (5)
Long-term remission of paraprotein-induced immunotactoid glomerulopathy after high-dose therapy and autologous blood stem cell transplantation (2007) (5)
Cell cycle arrest and cell death correlate with the extent of ischaemia and reperfusion injury in patients following kidney transplantation – results of an observational pilot study (2018) (5)
Hantavirus infection presenting as acute renal failure (1990) (5)
Prescription of Calcium Concentration and Pth Control (1996) (5)
The response of GFR to amino acids differs between autosomal dominant polycystic kidney disease (ADPKD) and glomerular disease. (1992) (5)
Monitoring of gene expression in tacrolimus‐treated de novo renal allograft recipients facilitates individualized immunosuppression: Results of the IMAGEN study (2021) (5)
[Nonocclusive intestinal ischemia as a complication of hemodialysis treatment]. (1993) (5)
PHARMACOKINETIC AND PHARMACODYNAMIC COMPARISON OF AN INITIALLY INTENSIFIED DOSING REGIMEN VERSUS A STANDARD DOSING REGIMEN OF ENTERIC-COATED MYCOPHENOLATE SODIUM (EC-MPS) IN RENAL TRANSPLANT PATIENTS.: 717 (2008) (5)
Increased peritoneal damage in glyoxalase 1 knock-down mice treated with peritoneal dialysis. (2015) (5)
Superior Renal Function in an Everolimus-Based Calcineurin Inhibitor Free Regimen Compared to Standard Cyclosporine/Mycophenolate and Low Cyclosporine/Everolimus: Follow-Up of the HERAKLES Study at Month 36.: Abstract# 716 (2014) (5)
SAFETY AND EFFICACY OF REDUCED OR FULL DOSE OF CYCLOSPORINE (NEORAL®) IN COMBINATION WITH MYCOPHENOLATESODIUM (MYFORTIC®), BASILIXIMAB (SIMULECT®), AND STEROIDS IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS (2004) (5)
Emerging drugs for the treatment of transplant rejection (2011) (5)
Deepening coma in an epileptic patient: the missing link to the urea cycle (2002) (4)
Effect of uninephrectomy in ADPKD. (1995) (4)
Selective Blocking of TNF Receptor 1 Attenuates Peritoneal Dialysis Fluid Induced Inflammation of the Peritoneum in Mice (2016) (4)
Increased Cyclosporin A Sensitivity In Vivo in Pediatric Renal Transplant Recipients Compared With Adults (2012) (4)
Autosomal dominant polycystic kidney disease. (1999) (4)
Is There a Need for Additional DQ Matching? (2018) (4)
Endstage Renal Failure in Diabetes Mellitus: Special Problems of Treatment and Monitoring (2001) (4)
Higher CD19+CD25+ Bregs are independently associated with better graft function in renal transplant recipients (2021) (4)
[Combined liver-kidney and kidney after liver transplantation: indications and experiences from a nephrological perspective at a single center]. (2010) (4)
The patient with C-ANCA/PR3-ANCA-positive crescentic pauci-immune glomerulonephritis and recurrence of nephritic sediment. (2008) (4)
Increased risk of infection‐associated death with incompatible kidney transplantations (2017) (4)
Polar release of pathogenic Old World hantaviruses from renal tubular epithelial cells (2012) (4)
Immunosuppression after kidney transplantation. (2011) (4)
An elderly nursing home resident with unusual urine bag discoloration (2011) (4)
COMPARISON OF AN INITIALLY INTENSIFIED DOSING REGIMEN VERSUS A STANDARD DOSING REGIMEN OF ENTERIC-COATED MYCOPHENOLATE SODIUM (EC-MPS) IN RENAL TRANSPLANT PATIENTS: EFFICACY AND SAFETY ANALYSIS OF 75 PATIENTS.: 266 (2008) (4)
Spontaneous lymphoblastoid cell lines from patients with Epstein-Barr virus infection show highly variable proliferation characteristics that correlate with the expression levels of viral microRNAs (2019) (4)
Natural SARS-CoV-2 infection results in higher neutralization response against variants of concern compared with 2-dose BNT162b2 vaccination in kidney transplant recipients (2021) (4)
Optimal blood pressure control versus additional immunosuppressive therapy in idiopathic membranous nephropathy - a retrospective analysis. (2009) (4)
Bioimpedance analysis is not superior to clinical assessment in determining hydration status: A prospective randomized‐controlled trial in a Western dialysis population (2021) (4)
Efficacy and Safety of Three Different Treatment Regimens in de Novo Renal Transplant Patients: Results of the HERAKLES Trial: 1722 (2012) (4)
Gastrointestinal hemorrhage in hemodialysis patients. (2008) (4)
Association of low serum TGF-β level in hantavirus infected patients with severe disease (2015) (4)
No 'Stinkefinger' and renal failure--do you see a link? Diagnosis: acrorenal syndrome. (1999) (4)
A case of strange cardiac rhythms (2012) (4)
Sudden development of low tolerance of dialysis in a young female patient (2004) (3)
Cells of the human respiratory tract support the replication of pathogenic Old World orthohantavirus Puumala (2021) (3)
[Beta 2-microglobulin-induced amyloidosis. A new complication of long-term hemodialysis]. (2008) (3)
Impaired Neutralizing Antibody Activity against B.1.617.2 (Delta) after Anti-SARS-CoV-2 Vaccination in Patients Receiving Anti-CD20 Therapy (2022) (3)
Fever, acute renal failure and pulmonary edema (2011) (3)
Soluble Urokinase Receptor and Mortality in Kidney Transplant Recipients (2022) (3)
Long-term Surgical Outcome and Risk Factors in Living Kidney Donors. (2020) (3)
Prospective Phase II Study Using Dexamethasone Induction Therapy and High-Dose Melphalan Chemotherapy Followed by Autologous Stem Cell Transplantation in 30 Patients with Systemic AL Amyloidosis. (2009) (3)
Pre-transplant CD200 and CD200R1 concentrations are associated with post-transplant events in kidney transplant recipients (2019) (3)
Superiority of AbCross enzyme-linked immunosorbent assay cross-match over the B-cell complement-dependent lymphocytotoxicity cross-match. (2013) (3)
Desensitization of HLA-incompatible kidney recipients. (2011) (3)
Initiatives focusing on transplantation highlight talks at NKF annual meeting. (2009) (3)
CAPD: Developments during Changing Times (2009) (3)
Efficacy and Safety of Three Different Treatment Regimens in De Novo Renal Transplant Patients: Month 36 Follow-Up Results of HERAKLES Trial.: Abstract# 718 (2014) (3)
Analysis of de novo donor‐specific HLA‐DPB1 antibodies in kidney transplantation (2021) (3)
S282: A RANDOMIZED CONTROLLED CLINICAL TRIAL DEMONSTRATES THAT PLASMA FROM CONVALESCENT AND VACCINATED DONORS IMPROVES OUTCOME OF COVID-19 IN PATIENTS WITH HEMATOLOGICAL DISEASE, CANCER OR IMMUNOSUPPRESSION (2022) (3)
A generalized seizure in a renal allograft recipient. (2005) (3)
Kidney and hypertension-causes. Update 2003. (2003) (3)
Reporting Quality-of-Life Outcomes in Clinical Trials of Immunosuppressive Therapy in Kidney Transplantation. (2016) (3)
Current pharmacotherapeutical options for the prevention of kidney transplant rejection (2013) (2)
Impaired Differentiation of Highly Proliferative ICOS+-Tregs Is Involved in the Transition from Low to High Disease Activity in Systemic Lupus Erythematosus (SLE) Patients (2021) (2)
DIALYZING THE ELDERLY: ISSUES AND CONCERNS: Cardiovascular Abnormalities and Hypertension in the Elderly Dialysis Patient (2002) (2)
Tuberculosis, acute kidney injury and pancreatitis––what is the underlying cause? (2012) (2)
Cyclophosphamide induction dose and outcomes in ANCA-associated vasculitis with renal involvement (2021) (2)
[ACE Inhibitors and ARB in Chronic Kidney Disease: What Has to Be Considered]. (2018) (2)
Validating Consensus-Defined Severity Grading of Lymphatic Complications after Kidney Transplant (2021) (2)
A need-adapted transition program after pediatric kidney transplantation (2019) (2)
Opinion: How Can the Poor Outcomes for Diabetic Dialysis Patients be Improved? (2004) (2)
Relapsing oligosymptomatic fever in a kidney-pancreas transplant recipient (2004) (2)
Membranous nephropathy followed by anti-glomerular basement disease: A case report and review of clinical presentation and treatment (2018) (2)
No `Stinkefinger' and renal failuredo you see a link? (1999) (2)
Proton pump inhibitors interfere with the immunosuppressive potency of mycophenolate mofetil RHEUMATOLOGY (2010) (2)
Risk factors of long-term postoperative renal function after partial nephrectomy in a solitary kidney (2017) (2)
Living Donor Kidney Transplantation in Patients With Donor-Specific HLA Antibodies After Desensitization With Immunoadsorption (2018) (2)
CD4+CD25+CD127-Foxp3+ and CD8+CD28- Tregs in Renal Transplant Recipients: Phenotypic Patterns, Association With Immunosuppressive Drugs, and Interaction With Effector CD8+ T Cells and CD19+IL-10+ Bregs (2021) (2)
Prophylactic onlay reinforcement with absorbable mesh (polyglactin) is associated with less early wound complications after kidney transplantation: A preliminary study. (2019) (2)
Pseudoporphyria Cutanea Tarda and Non-A Non-S Hepatitis in a CAPD Patient (1987) (2)
Compelling drug indications in diabetic and nondiabetic nephropathy (2004) (2)
Clinical outcomes after ABO-incompatible renal transplantation (2019) (2)
Contrast-enhanced sonography as early diagnostic tool of chronic allograft nephropathy. (2006) (2)
Cardiovascular complications after renal transplantation (1999) (2)
Incidences of Infectious Events in a Renal Transplant Cohort of the German Center of Infectious Diseases (DZIF) (2022) (2)
H2 - Differential effects of antihypertensive treatment on the development of glomerulosclerosis in subtotally nephrectomized rats (1995) (2)
Cardiovascular complications - 3 (2009) (2)
Efficacy and Safety of Checkpoint Inhibitor Treatment in Patients with Advanced Renal or Urothelial Cell Carcinoma and Concomitant Chronic Kidney Disease: A Retrospective Cohort Study (2021) (2)
Effectiveness of different immunoadsorption columns for anti-A/B antibody depletion. (2019) (2)
H1DIFFERENTIAL EFFECTS OF ANTIHYPERTENSIVE TREATMENT ON ABNORMAL CARDIAC STRUCTURE IN EXPERIMENTAL UREMIA (1995) (1)
Induction of Long-Lasting Regulatory B Lymphocytes by Modified Immune Cells in Kidney Transplant Recipients (2022) (1)
Liquefaction necrosis of mitral annulus calcification in a patient with chronic renal failure: an unrecognized diagnosis. (2007) (1)
INITIAL INTENSIFIED DOSING OF ENTERIC-COATED MYCOPHENOLATE SODIUM (EC-MPS) VERSUS STANDARD DOSING IMPROVES REJECTION PROPHYLAXIS IN DE NOVO RENAL TRANSPLANT RECIPIENTS: 1592 (2010) (1)
Expression Profile of Human Renal Mesangial Cells Is Altered by Infection with Pathogenic Puumala Orthohantavirus (2022) (1)
TNF Signaling in Peritoneal Mesothelial Cells: Pivotal Role of cFLIPL (2017) (1)
[Cystic kidneys (autosomal dominant polycystic kidney disease)]. (1994) (1)
AN INTENSIFIED DOSING OF ENTERIC-COATED MYCOPHENOLATE SODIUM IN RENAL TRANSPLANT PATIENTS RESULTS IN IMPROVED EFFICACY WITHOUT COMPROMISING SAFETY: 1 YEAR FOLLOW-UP RESULTS: 1709 (2010) (1)
Peritoneal dialysis - 3 (2009) (1)
Reversal of refractory antibody-mediated rejection in blood group incompatible kidney transplantation by Eculizumab (2011) (1)
Progression of renal failure without proteinuria in a patient with type 1 diabetes (2004) (1)
COMPARABLE PATIENT REPORTED OUTCOMES WITH INITIALLY INTENSIFIED DOSING VERSUS STANDARD DOSING OF ENTERIC-COATED MYCOPHENOLATE SODIUM (EC-MPS) IN DE NOVO RENAL TRANSPLANT RECIPIENTS: 1571 (2010) (1)
12th International Vasculitis and ANCA Workshop. June 15–18, 2005, Heidelberg, Germany (2005) (1)
Hand-Assisted laparoscopic donor nephrectomy PERiumbilical versus Pfannenstiel incision and return to normal physical ACTivity (HAPERPACT): study protocol for a randomized controlled trial (2018) (1)
Common T-Cell-Receptor Motifs and Features in Patients with Cytomegalovirus (CMV)-Seronegative End-Stage Renal Disease Receiving a Peptide Vaccination against CMV (2022) (1)
The bedridden osteomalacic patient with Fanconi syndrome in pre-terminal renal failure. (2000) (1)
Perirenal fibrosis: make your diagnosis (2013) (1)
Impact of Surgeon's Experience on Vascular and Haemorrhagic Complications After Kidney Transplantation (2019) (1)
PREventive effect of FENestration with and without clipping on post-kidney transplantation lymphatic complications (PREFEN): study protocol for a randomised controlled trial (2020) (1)
Lysozyme amyloidosis—a report on a large German cohort and the characterisation of a novel amyloidogenic lysozyme gene variant (2022) (1)
Biopsy-proven acute interstitial nephritis after SARS-CoV-2 mRNA vaccination—adverse vaccine side effect or unrelated complication from self-medication? Lessons for the clinical nephrologist (2022) (1)
Immune Response to COVID-19 mRNA Vaccination in Previous Nonresponder Kidney Transplant Recipients After Short-term Withdrawal of Mycophenolic Acid 1 and 3 Months After an Additional Vaccine Dose (2023) (1)
Renal cell cancer--a multimodal approach to preserving renal function and improving survival. (2011) (1)
1189: TRANSCRIPTOMIC ENDOTYPES IMPLICATE A UNIQUE RISK PROFILE FOR KIDNEY-RELATED OUTCOMES IN SEPSIS (2022) (1)
Peritoneal dialysis - 1 (2014) (1)
The patient with ADPKD on maintenance hemodialysis. (1995) (1)
[The serological diagnosis of Hantaan virus infections]. (2008) (1)
TCT-208 Catheter-based renal sympathetic denervation – results of the heidelberg registry (2012) (1)
Persistence of glomerular amyloid after autologous blood stem cell transplantation in Al-amyloidosis despite remission of nephrotic syndrome. (2002) (1)
Functional Consequences of Old World Hantavirus Infection in Human Renal Cells (2017) (1)
HIGH RESPONDER RATE AFTER CALCINEURIN-INHIBITOR WITHDRAWL AND INTRODUCTION OF SIROLIMUS THERAPY IN PATIENTS WITH DETERIORATING RENAL FUNCTION. (2006) (1)
Are We Treating the Right People? Are We Treating the People Right? Health Status, Knowledge and Quality of Life amongst Patients with Diabetes at a Specialized Clinic at Kamuzu Central Hospital, Malawi (2016) (1)
Unmet clinical needs in dialysis: what can we do? (2001) (1)
Post Hoc Analysis of ZEUS and HERAKLES, Two Prospective, Open-Label, Multicenter, Randomized Trials: Onset and Progression of Diabetes in Kidney Transplant Recipients On Cyclosporine Standard or Converted to CNI-Free or CNI-Low Everolimus Regimen.: Abstract# 2921 (2014) (1)
[Renal involvement in amyloidosis and sarcoidosis]. (2018) (1)
Increased Serum Kynurenine Level is Associated with Severity of Kidney Injury in Puumala Hantavirus Infection (2014) (1)
Prophylactic Peritoneal Fenestration during Kidney Transplantation Can Reduce the Type C Lymphocele Formation (2021) (1)
Tissue Expression of Aquaporin 2 Is Correlated to Urine Output and Allograft Function in Sensitized Kidney Transplant Patients. (2016) (1)
Das Tumorlysesyndrom (2015) (1)
Continuous Ambulatory Peritoneal Dialysis – Developments during Changing Times (2008) (1)
POOLED ANALYSIS OF THREE PROSPECTIVE, 12-MONTH, MULTICENTER STUDIES OF ENTERIC-COATED MYCOPHENOLATE SODIUM (MYFORTIC®) IN DE NOVO RENAL TRANSPLANT PATIENTS. (2006) (1)
Report on training sessions at the Prishtina University Hospital Department of Nephrology and Dialysis Unit, 22-29 July 2000, by the Joint Action Nephrology Eastern Europe of ISN and EDTA/ERA. (2001) (1)
2077 Detection and differentiation of myocardial delayed contrast enhancement patterns by cardiac mri in patients with end stage renal disease (2008) (1)
Transplantation: Molecular diagnosis of kidney transplant rejection (2014) (1)
REDUCTION OF IFN-GAMMA PLASMA LEVELS EARLY POSTTRANSPLANT IN RENAL TRANSPLANT PATIENTS WITH THYMOGLOBULIN INDUCTION THERAPY: 1953 (2008) (0)
Chronic Kidney Failure Provokes the Enrichment of Terminally Differentiated CD8+ T Cells, Impairing Cytotoxic Mechanisms After Kidney Transplantation (2022) (0)
[Vascular access for hemodialysis: will the tunnelled atrial catheter solve the problems?]. (2004) (0)
Jaccoud ’ s nephritis Introduction (2005) (0)
Serological response and disease-specific neutralizing antibodies in kidney transplant recipients with SARS-CoV-2 infection – a case series (2020) (0)
Hepatic and Renal Failure after Anterior Myocardial Infarction Induced Apical Ventricular Septal Defect (2011) (0)
[A zoonotic viral threat: news about hantavirus disease]. (2014) (0)
Regional wall motion abnormalities at rest and stress in patients with end-stage renal disease diagnosed by cardiac magnetic resonance imaging (2009) (0)
The Epstein-Barr virus induces the expression of the LPAM-1 1 integrin in B-cells in vitro and in vivo 2 (2018) (0)
T.70. Different Mechanisms of Immunosuppression Caused by Cyclosporine A (CsA) and FK506 (2009) (0)
The Extent of HLA-DR Expression on HLA-DR+ Tregs Allows the Identification of Patients with Clinically Relevant Borderline Rejection: 814 (2012) (0)
Supported by an educational grant from Colchicum ad nauseum (2003) (0)
Differential effects of everolimus on human fibroblast- and proximal tubular epithelial cells in culture Possible clinical implications (2003) (0)
Supported by an educational grant from A renal biopsy yields sight as well as insight (2003) (0)
Unusual skin lesions in a haemodialyzed patient (2011) (0)
High-Dose Melphalan Chemotherapy with Autologous Stem Cell Transplantation in 65 Patients with Al Amyloidosis: ORGAN PROGRESSION CAN BE DELAYED IN PATIENTS REACHING COMPLETE REMISSION (2007) (0)
[KDIGO guideline on the evaluation and management of candidates for kidney transplantation]. (2022) (0)
KLKB1 and CLSTN2 are associated with HDL-mediated cholesterol efflux capacity in a genome-wide association study. (2023) (0)
Long-Term Results of Pediatric Living Donor Kidney Transplantation at the University of Heidelberg: 2487 (2010) (0)
A SINGLE CENTRE EXPERIENCE OF 214 KIDNEY TRANSPLANTATIONS FOLLOWING POLYCYSTIC KIDNEY DISEASE: 2550 (2010) (0)
Allograft small cell carcinoma after kidney transplantation (2004) (0)
PAR-3 Activation by Activated Protein C: a Novel Podocyte Protective Signalling Pathway (2010) (0)
Soluble urokinase plasminogen activation receptor and long-term outcomes in persons undergoing coronary angiography (2019) (0)
Nephrology Grand Rounds Clinical Issues in Nephrology (1998) (0)
Contents, Vol. 14, 1994 (1993) (0)
Renal transplantation - clinical studies - 2 (2009) (0)
Rhabdomyolysis and elevated liver function tests—what’s the underlying cause? (2011) (0)
Obesity surgery in patients with end-stage organ failure: Is it worth it? (2021) (0)
Validating Consensus-Deﬁned Severity Grading of Lymphatic Complications after Kidney Transplant (2021) (0)
Why is a shrunken bladder and a nephrotic kidney an expression of the same disease (2004) (0)
SP774OUTCOMES AND COMPLICATIONS FOLLOWING ABO-INCOMPATIBLE KIDNEY TRANSPLANTATION PERFORMED AFTER DESENSITIZATION BY SEMI-SELECTIVE IMMUNOADSORPTION (2019) (0)
Introduction (2006) (0)
Contents Vol. 91, 2002 (2002) (0)
SaO011A PHASE-I CLINICAL TRIAL OF DONOR-DERIVED MIC CELL INFUSION FOR THE INDUCTION OF DONOR-SPECIFIC HYPORESPONSIVENESS AFTER LIVING DONOR KIDNEY TRANSPLANTATION (TOL-1 STUDY) (2018) (0)
Report on the 1st Balkan Nephrology School held in Prishtina/Kosova and on the first living related kidney transplantation at the University Hospital of Prishtina, 23 26 May 2007 (2007) (0)
TRANSPLANTATION BASIC SCIENCE, ALLOGENIC AND XENOGENIC TOLERANCE (2014) (0)
Individualised immunosuppression with intravenously administered donor-derived modified immune cells compared with standard of care in living donor kidney transplantation (TOL-2 Study): protocol for a multicentre, open-label, phase II, randomised controlled trial (2022) (0)
Transplant Quality Programs (2014) (0)
suPAR links a dysregulated immune response to tissue inflammation and sepsis-induced acute kidney injury (2023) (0)
Painful haematuria following central venous catheter infection (2003) (0)
Hypokalaemia and hypertension early after kidney transplantation (2002) (0)
[The metastases of an occult bronchial carcinoma in a transplanted kidney. A case report on the differential diagnosis of multiple space-occupying lesions in a transplanted kidney]. (1994) (0)
NEPHROLOGY GRAND ROUNDS Malignancy After Renal Transplantation (2002) (0)
[Polycystic kidney disease: recent developments]. (1987) (0)
Abdominal gas is not always bowel associated: lessons from an allograft recipient (2004) (0)
SP676THE ROLE OF AGE-RELATED T CELL DIFFERENTIATION IN DIALYSIS PATIENTS (2017) (0)
A Phase-I Clinical Trial of Donor-Derived MIC Cell Infusion for the Induction of Donor-Specific Hyporesponsiveness after Living Donor Kidney Transplantation (TOL-1 study) (2018) (0)
Supported by an educational grant from Dialysis-resistant pulmonary oedema (2003) (0)
Cell signalling / Pathophysiology (2012) (0)
High-dose melphalan chemotherapy with autologous stem cell transplantation in 44 patients with AL amyloidosis: a single-centre experience (2005) (0)
Supported by an educational grant from Hypercalcaemia and acute renal failure (2001) (0)
Disease of the Month Hantavirus Infection (2005) (0)
Supported by an educational grant from Acute renal failure after bacteraemia and endocarditis (2001) (0)
What's in a blister? A diagnostic twister (2004) (0)
Transplant-Associated Renal Microangiopathy Is Associated with a High Risk of Refractory Gvhd and Characterized By a Specific Biomarker Signature (2014) (0)
7 Modified immune cell therapy ameliorates murine lupus nephritis and induces regulatory cell subsets (2019) (0)
IL-23 plasma level is strongly associated with CMV status and reactivation of CMV in renal transplant recipients (2016) (0)
Akutes Nierenversagen (2009) (0)
Authorsʼ Reply: Urinary Cytokines in BK Viruria (2010) (0)
Supported by an educational grant from Painful haematuria following central venous catheter infection (2003) (0)
Rapid deterioration of renal function in a long-term allograft recipient with recurrent IgA nephritis—is it the only cause? (2007) (0)
Bariatric surgery in patients with obesity and end-stage renal disease. (2023) (0)
A 35-YEAR SINGLE-CENTER EXPERIENCE OF RENAL TRANSPLANTATION USING KIDNEYS HARVESTED FROM LIVING DONORS (2004) (0)
Poor ultrafiltration shortly after peritoneal dialysis initiation (2002) (0)
FP190MODIFIED IMMUNE CELL THERAPY AMELIORATES MURINE LUPUS NEPHRITIS AND INDUCES REGULATORY CELL SUBSETS (2019) (0)
Transplantation / Basic research (2011) (0)
Pharmacodynamic Controlled Tapering of Cyclosporine A: A New Step Towards Individualized Immunosuppressive Therapy in Transplanted Patients (2007) (0)
OP0040 MODIFIED IMMUNE CELL THERAPY AMELIORATES MURINE LUPUS NEPHRITIS AND INDUCES REGULATORY CELL SUBSETS (2019) (0)
P0413THE ICOS+ TREG/ICOS+ TRESP BALANCE HAS A DECISIVE ROLE REGARDING THE PRESERVATION OF THE REMISSION PHASE IN SLE PATIENTS (2020) (0)
Subject Index Vol. 14, 1994 (1994) (0)
Decision-making processes prior to living kidney donation (2003) (0)
Shift in Living Kidney Donor Demographics Over the Past 50 Years in a German Transplant Center (2021) (0)
Acute renal dysfunction after renal transplantation (1998) (0)
Renal transplantation - clinical studies - 3 (2009) (0)
The Silence of Organizations: How Organizations Cover up Wrongdoings (2021) (0)
Pulmonary cavernae in Wegener's granulomatosis. (2006) (0)
[Diabetic nephropathy]. (2007) (0)
Report on the 1st Balkan Nephrology School held in Prishtina/Kosova and on the first living related kidney transplantation at the University Hospital of Prishtina, 23–26 May 2007 (2007) (0)
An uncommon cause of metabolic acidosis in a haemodialysis patient (2002) (0)
Invited commentary: advantages and cautions for developing valid prognostic models of simultaneous pancreas and kidney transplantation outcomes (2018) (0)
[Acute renal failure and hypertension crisis after a technoparty]. (2003) (0)
Polar release of pathogenic Old World hantaviruses from renal tubular epithelial cells (2012) (0)
Concurrent light chain amyloidosis and proximal tubulopathy: Insights into different aggregation behavior—A case report (2022) (0)
Clinical Relevance of a Positive B-Cell CDC Crossmatch before Renal Transplantation: 2209 (2012) (0)
Peculiarly progressive tetraplegia (2013) (0)
[Dietary aspects and nutritional guidelines in kidney diseases]. (1993) (0)
A 12-year-old boy with renal failure and haemoptysis (2013) (0)
Contents Vol. 96, 2004 (2004) (0)
Nierenlebendspende (2002) (0)
R2206 Anti-neutrophil cytoplasmic antibodies in severe infection a neglected association (2007) (0)
suPAR and chronic kidney disease—a podocyte story (2017) (0)
Preoperative CD52 Level Predicts Graft Survival following Kidney Transplantation (2022) (0)
Enhanced Sensitivity to Cyclosporine-Induced Suppression of Intracellular Interleukin-2 Expression In Vivo in Paediatric vs. Adult Renal Transplant Recipients: 2098 (2012) (0)
Headache and a syndrome of bilateral hydronephrosis (2002) (0)
[Ambulatory 24-hour blood pressure monitoring of children and young adults with autosome dominant polycystic kidney degeneration]. (1992) (0)
Therapeutic drug monitoring detects high interpatient variability in response to mycophenolic acid treatment in patients with ANCA-associated vasculitis (2013) (0)
Seizures and renal failure : is there a link ? (2005) (0)
The family clinic at Tygerberg hospital: the first year. (1998) (0)
Glomerular filtration barrier dysfunction in an RNA virus-induced glomerulopathy resembles findings of common nephrotic syndromes (2020) (0)
Differential prognostic utility of adiposity measures in chronic kidney disease. (2023) (0)
Results of a Patient Survey for Assessment Services in Renal Transplant Patients With a History of Cancer (2017) (0)
Anasarca secondary to problems in three organs : one man with three diseases ? (2004) (0)
EVALUATION OF PATIENTS OFFERING A KIDNEY FOR LIVING DONATION KIDNEY TRANSPLANTATION AT THE UNIVERSITY OF HEIDELBERG - A FOUR DECADES SINGLE CENTER EXPERIENCE - (2010) (0)
Examination of Serum miRNAs as Possible Biomarkers for the Diagnosis of Acute Rejection after Kidney Transplantation (2018) (0)
Cells of the human respiratory tract support the replication of pathogenic Old World orthohantavirus Puumala (2021) (0)
Induction of Donor-Specific Immune Tolerance with Clinical MIC Cell Infusion — a Phase I Study (TOL-1) (2018) (0)
Synergistic effect of cinacalcet and active vitamin D in a dialysis patient with secondary hyperparathyroidism (2010) (0)
[What is your diagnosis? Bilateral dacryoadenitis]. (2007) (0)
Nierentransplantation@@@Renal transplantation (2015) (0)
Hyperpnoea and ketonuria in an HIV-infected patient (2007) (0)
Association of low serum TGF-β level in hantavirus infected patients with severe disease (2015) (0)
Innovations in transplantation Medicine. Introduction. (2009) (0)
Hypertension after renal transplantation. (2001) (0)
Human Leucocyte Antigen-Matching Can Improve Long Term Outcome of Renal Allografts from Donors Older Than 75 Years. (2023) (0)
341 Interdisciplinary counseling service for renal malignancies: Patients and physicians view of a new model of care (2013) (0)
Transplant-associated inflammatory breast disease (2002) (0)
Acute Allograft Rejection and Polyoma BK-Virus Infection Are Associated with Pre-Transplant Plasma Neopterin in Kidney Transplant Recipients: 1055 (2012) (0)
RISK FOR INFECTION, MALIGNANCY AND RENAL ALLOGRAFT FUNCTION IN STABLE RENAL TRANSPLANTED PATIENTS DEPENDS ON INHIBITION OF NFAT-REGULATED GENE EXPRESSION. (2006) (0)
Orange-like skin lesion and hypertension—what is the link? (2004) (0)
[Antihypertensive therapy in diabetic patients. Almost as important as controlling blood glucose]. (2000) (0)
The Ongoing Need for Innovation in Transplant Medicine and Surgery (2005) (0)
The receptor for advanced glycation end-products (RAGE) plays a key role in the formation of nanotubes (NTs) between peritoneal mesothelial cells and in murine kidneys (2014) (0)
Images in Nephrology (Section Editor: G. H. Neild) Pulmonary cavernae in Wegener's granulomatosis (2006) (0)
Subject Index Vol. 91, 2002 (2002) (0)
FP313CELL CYCLE BIOMARKERS AND SUPAR OUTPERFORM STANDARD PARAMETERS FOR THE PREDICTION OF SEPSIS-INDUCED ACUTE KIDNEY INJURY REQUIRING RENAL REPLACEMENT THERAPY (2019) (0)
An old patient with end stage renal disease and sudden onset of confusion and lethargy (2006) (0)
FC 043SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR (SUPAR) DETERMINES OUTCOMES IN CLINICAL AND EXPERIMENTAL SEPTIC ACUTE KIDNEY INJURY (2021) (0)
Expanding pancreas donor pool by evaluation of unallocated organs after brain death (2020) (0)
FP306 THE IMPACT OF THE QUALITY OF HEMODIALYSIS WATER ON CHRONIC INFLAMMATION AND ITS CONSEQUENCES (2007) (0)
A woman with ascites and oliguria (2013) (0)
F.98. Pharmacodynamic Cyclosporin-A Monitoring Shows a Close Relationship Between Individual Degree of Immunosuppression and Incidence of Malignant Diseases (2008) (0)
All-cause and cancer-specific overall survival in kidney transplant recipients with pre-transplant malignancies in a German cohort (2020) (0)
Development of Potency Assays for Quality Assessment of an Advanced Therapy Medicinal Product: Mitomycin C-Induced Peripheral Blood Mononuclear Cell (MIC) Product (2018) (0)
VAD Chemotherapy Followed by Autologous Stem Cell Transplantation (ASCT) for the Treatment of Nephrotic Syndrome in Light Chain (AL) Amyloidosis (2004) (0)
Acute renal failure - basic research (2009) (0)
Herz Kidney and Hypertension – Causes Update 2003 (0)
Introduction (2009) (0)
Hypercalcaemia-induced renal failure—a mystery (2002) (0)
Supported by an educational grant from Ear and kidney malformations with renal failure in an infant : what is the link ? (2003) (0)
TRANSPLANTATION IN PATIENTS WITH DONOR-SPECIFIC HLA ANTIBODIES AFTER DESENSITIZATION WITH IMMUNOADSORPTION ASSOCIATED WITH HIGHER GRAFT LOSS AND MORE ANTIBODY MEDIATED REJECTION CASES (2018) (0)
Giant cells and pneumonia in a transplant patient. What is the link (2002) (0)
Recurrent paroxysms of metabolic acidosis in a haemodialysis patient (2006) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Martin G. Zeier?

Martin G. Zeier is affiliated with the following schools:

Heidelberg University